한글목차

보충 요법(TRT) 시장 규모는 최근 꾸준히 성장하고 있습니다. 2025년 21억 1,000만 달러에서 2026년에는 22억 달러에 이르고, CAGR 3.9%의 성장이 전망되고 있습니다. 지난 수년간의 성장에는 성선기능저하증 유병률 증가, 경구용 테스토스테론 제제의 보급, 고령 인구 증가, 비뇨기과 및 내분비 전문의의 인식 개선, 주사제 테스토스테론 치료의 발전 등이 요인으로 작용한 것으로 보입니다.

보충 요법(TRT) 시장 규모는 향후 몇 년간 꾸준한 성장이 전망됩니다. 2030년에는 25억 7,000만 달러에 이르고, CAGR은 4.0%를 나타낼 전망입니다. 예측 기간 동안의 성장은 새로운 경피 흡수성 젤 패치 개발, 정밀의료 접근법의 발전, 재택 치료의 보급 확대, 테스토스테론 결핍증에 대한 임상 연구 확대, 남성 불임 및 건강 인식 증가에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 개인 맞춤형 호르몬 요법, 저침습적 투여법, 남성 성선기능저하증에 대한 인식 개선, 외래 진료소 및 전문 내분비학 센터의 확대, 재택형 테스토스테론 치료 솔루션의 성장 등이 있습니다.

테스토스테론 결핍증의 유병률 증가는 테스토스테론 대체요법 시장의 성장을 견인할 것으로 예측됩니다. 테스토스테론 결핍증(성선기능저하증이라고도 함)은 체내에서 충분한 양의 테스토스테론을 생산하지 못할 때 발생합니다. 테스토스테론 보충요법은 테스토스테론 수치를 생리적 범위로 회복시키고, 성선기능저하증의 영향을 역전시켜 성욕감퇴, 발기부전, 우울증, 빈혈, 근육감소 등의 증상을 완화하는 데 사용됩니다. 예를 들어, 2024년 3월 영국에 본사를 둔 미디어 및 기술 기업 PharmiWeb은 40-70세 남성의 테스토스테론 결핍증 발병률이 2.1%에서 5.73% 사이로 추정되며, 유병률은 최대 38.7%를 나타낼 것으로 추정된다고 보고한 바 있습니다. 입니다. 따라서 테스토스테론 결핍증 증가가 테스토스테론 대체요법 시장의 성장을 주도하고 있습니다.

테스토스테론 대체요법 시장의 주요 기업들은 경쟁 우위를 확보하기 위해 테스토스테론 사이피오네이트 주사제 도입에 주력하고 있습니다. 테스토스테론 사이피오네이트 주사제(USP)는 자연적으로 존재하는 남성 호르몬의 일종인 합성 테스토스테론 사이피오네이트를 함유하고 있습니다. 이 주사는 발기부전, 성선기능저하증 등 테스토스테론 결핍과 관련된 증상을 개선하기 위해 보충 요법(TRT)의 일환으로 일반적으로 처방됩니다. 예를 들어, 2023년 4월 미국 제약회사 시로메드(Xiromed LLC)는 테스토스테론 사이피오네이트 주사제(USP)를 출시했습니다. 이 주사제는 낮은 테스토스테론 수치 및 관련 질환을 치료하는 데 사용되며, 테스토스테론 수치를 건강한 범위로 회복시키는 데 도움이 됩니다. 테스토스테론 사이피오네이트 주사제는 테스토스테론 결핍증에 대한 가장 효과적인 치료법 중 하나로 여겨지고 있으며, 일반적으로 환자의 내약성이 우수합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Testosterone replacement therapy is a type of hormonal treatment used to address low testosterone (T) levels in males, which can occur due to aging or certain medical conditions.

The primary forms of testosterone replacement therapy include oral, implants, gels or creams, patches, buccal adhesives, parenteral, and other methods. Oral administration involves substances taken by mouth, such as tablets, capsules, syrups, and more. Low testosterone is typically treated in cases of hypogonadism, autoimmune conditions, genetic disorders, sex organ surgeries, and other related indications. Various active ingredients are used in these therapies, including testosterone, methyltestosterone, testosterone undecanoate, testosterone enanthate, and testosterone cypionate. These treatments are administered in hospitals, clinics, and other healthcare settings.

Tariffs have influenced the testosterone replacement therapy market by increasing costs for imported raw materials and delivery devices, affecting product availability in regions reliant on international suppliers. Oral, parenteral, and gel/cream segments are particularly impacted, with North America and Europe seeing higher price pressures. Manufacturers are exploring local production and alternative sourcing to maintain supply chains. Positively, tariffs are incentivizing domestic innovation and localized manufacturing of testosterone therapies.

The testosterone replacement therapy market research report is one of a series of new reports from The Business Research Company that provides testosterone replacement therapy market statistics, including testosterone replacement therapy industry global market size, regional shares, competitors with a testosterone replacement therapy market share, detailed testosterone replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the testosterone replacement therapy industry. This testosterone replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The testosterone replacement therapy market size has grown steadily in recent years. It will grow from $2.11 billion in 2025 to $2.2 billion in 2026 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to increasing prevalence of hypogonadism, availability of oral testosterone formulations, growing geriatric population, rising awareness among urologists and endocrinologists, advancements in injectable testosterone therapies.

The testosterone replacement therapy market size is expected to see steady growth in the next few years. It will grow to $2.57 billion in 2030 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to development of novel transdermal gels and patches, growth in precision medicine approaches, increasing adoption of home-administered therapies, expansion of clinical research in testosterone deficiency, rising male fertility and wellness awareness. Major trends in the forecast period include personalized hormonal therapy, minimally invasive delivery methods, rising awareness of male hypogonadism, expansion of outpatient clinics and specialized endocrinology centers, growth of home-based testosterone therapy solutions.

The increasing prevalence of testosterone deficiency is expected to drive the growth of the testosterone replacement therapy market. Testosterone deficiency, also known as hypogonadism, occurs when the body is unable to produce sufficient levels of testosterone. Testosterone replacement therapy is used to restore testosterone levels to a physiological range, reversing the effects of hypogonadism and alleviating symptoms such as reduced libido, erectile dysfunction, depression, anemia, muscle loss, and more. For instance, in March 2024, PharmiWeb, an England-based media and technology company, reported that the estimated incidence of symptomatic testosterone deficiency in men aged 40-70 years ranges from 2.1% to 5.73%, with a prevalence as high as 38.7%. Therefore, the rise in testosterone deficiency is driving the growth of the testosterone replacement therapy market.

Major companies in the testosterone replacement therapy market are increasingly focusing on introducing testosterone cypionate injections to gain a competitive edge. Testosterone Cypionate Injection (USP) contains synthetic testosterone cypionate, a form of the naturally occurring male sex hormone. This injection is commonly prescribed as part of testosterone replacement therapy to address conditions related to testosterone deficiency, such as erectile dysfunction and hypogonadism. For example, in April 2023, Xiromed LLC, a US-based pharmaceutical company, launched Testosterone Cypionate Injection (USP). This injectable form of testosterone is used to treat low testosterone levels and related conditions, helping to restore testosterone to a healthy range. Testosterone cypionate injections are considered one of the most effective treatments for testosterone deficiency and are generally well-tolerated by patients.

In January 2024, Lipocine, Inc., a US-based biopharmaceutical company specializing in oral testosterone replacement therapies, partnered with Verity Pharma to expand the commercialization and market reach of its hormone-based treatments. The partnership aims to leverage Verity Pharma's regulatory and commercialization expertise to accelerate the market entry and adoption of Lipocine's oral testosterone replacement therapy, TLANDO, in the U.S. and Canada. Verity Pharma, a Canada-based specialty pharmaceutical company, focuses on the regulatory, marketing, and distribution of specialty therapeutics, including testosterone replacement therapies.

Major companies operating in the testosterone replacement therapy market are AbbVie Inc., Acerus Pharmaceuticals Corporation, Antares Pharma Inc., Bayer Aktiengesellschaft, BioTE Medical LLC, Clarus Therapeutics Inc., Eli Lilly and Company, Endo International plc, Pfizer Inc., Teva Pharmaceutical Industries Limited, Acrux Limited, Aytu BioPharma Inc., Cipla Limited, Sun Pharmaceutical Industries Limited, Mylan N.V., Bausch Health Companies Inc., Sandoz International GmbH, Besins Healthcare, Coloplast A/S, Recordati S.p.A.

North America was the largest region in the testosterone replacement therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the testosterone replacement therapy market report during the forecast period. The regions covered in the testosterone replacement therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the testosterone replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The testosterone replacement therapy market includes revenues earned by entities by providing hormone testing, semen analysis, pituitary imaging, genetic studies, and testicular biopsy to treat low testosterone deficiency. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Testosterone Replacement Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses testosterone replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for testosterone replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The testosterone replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Oral; Implants; Gel Or Creams; Patches; Buccal Adhesive; Parenteral; Other Products
• 2) By Indication: Hypogonadism; Genetic Disorders; Sex Organ Surgeries; Other Indications
• 3) By Active Ingredient Type: Testosterone; Methyl Testosterone; Testosterone Undecanoate; Testosterone Enanthate; Testosterone Cypionate
• 4) By End User: Hospitals; Clinics; Other End-User
• Companies Mentioned: AbbVie Inc.; Acerus Pharmaceuticals Corporation; Antares Pharma Inc.; Bayer Aktiengesellschaft; BioTE Medical LLC; Clarus Therapeutics Inc.; Eli Lilly and Company; Endo International plc; Pfizer Inc.; Teva Pharmaceutical Industries Limited; Acrux Limited; Aytu BioPharma Inc.; Cipla Limited; Sun Pharmaceutical Industries Limited; Mylan N.V.; Bausch Health Companies Inc.; Sandoz International GmbH; Besins Healthcare; Coloplast A/S; Recordati S.p.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Testosterone Replacement Therapy Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Testosterone Replacement Therapy Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Testosterone Replacement Therapy Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Testosterone Replacement Therapy Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Personalized Hormonal Therapy
  • 4.2.2 Minimally Invasive Delivery Methods
  • 4.2.3 Rising Awareness Of Male Hypogonadism
  • 4.2.4 Expansion Of Outpatient Clinics And Specialized Endocrinology Centers
  • 4.2.5 Growth Of Home-Based Testosterone Therapy Solutions

5. Testosterone Replacement Therapy Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Specialty Endocrinology Centers
• 5.4 Home Healthcare Providers
• 5.5 Fertility And Wellness Centers

6. Testosterone Replacement Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Testosterone Replacement Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Testosterone Replacement Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Testosterone Replacement Therapy Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Testosterone Replacement Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Testosterone Replacement Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Testosterone Replacement Therapy Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Testosterone Replacement Therapy Market Segmentation

• 9.1. Global Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Implants, Gel Or Creams, Patches, Buccal Adhesive, Parenteral, Other Products
• 9.2. Global Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hypogonadism, Genetic Disorders, Sex Organ Surgeries, Other Indications
• 9.3. Global Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, Testosterone Cypionate
• 9.4. Global Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Other End-User

10. Testosterone Replacement Therapy Market Regional And Country Analysis

• 10.1. Global Testosterone Replacement Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Testosterone Replacement Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Testosterone Replacement Therapy Market

• 11.1. Asia-Pacific Testosterone Replacement Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Testosterone Replacement Therapy Market

• 12.1. China Testosterone Replacement Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Testosterone Replacement Therapy Market

• 13.1. India Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Testosterone Replacement Therapy Market

• 14.1. Japan Testosterone Replacement Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Testosterone Replacement Therapy Market

• 15.1. Australia Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Testosterone Replacement Therapy Market

• 16.1. Indonesia Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Testosterone Replacement Therapy Market

• 17.1. South Korea Testosterone Replacement Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Testosterone Replacement Therapy Market

• 18.1. Taiwan Testosterone Replacement Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Testosterone Replacement Therapy Market

• 19.1. South East Asia Testosterone Replacement Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Testosterone Replacement Therapy Market

• 20.1. Western Europe Testosterone Replacement Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Testosterone Replacement Therapy Market

• 21.1. UK Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Testosterone Replacement Therapy Market

• 22.1. Germany Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Testosterone Replacement Therapy Market

• 23.1. France Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Testosterone Replacement Therapy Market

• 24.1. Italy Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Testosterone Replacement Therapy Market

• 25.1. Spain Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Testosterone Replacement Therapy Market

• 26.1. Eastern Europe Testosterone Replacement Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Testosterone Replacement Therapy Market

• 27.1. Russia Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Testosterone Replacement Therapy Market

• 28.1. North America Testosterone Replacement Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Testosterone Replacement Therapy Market

• 29.1. USA Testosterone Replacement Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Testosterone Replacement Therapy Market

• 30.1. Canada Testosterone Replacement Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Testosterone Replacement Therapy Market

• 31.1. South America Testosterone Replacement Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Testosterone Replacement Therapy Market

• 32.1. Brazil Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Testosterone Replacement Therapy Market

• 33.1. Middle East Testosterone Replacement Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Testosterone Replacement Therapy Market

• 34.1. Africa Testosterone Replacement Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Testosterone Replacement Therapy Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Active Ingredient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Testosterone Replacement Therapy Market Regulatory and Investment Landscape

36. Testosterone Replacement Therapy Market Competitive Landscape And Company Profiles

• 36.1. Testosterone Replacement Therapy Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Testosterone Replacement Therapy Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Testosterone Replacement Therapy Market Company Profiles
  • 36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Acerus Pharmaceuticals Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Antares Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. BioTE Medical LLC Overview, Products and Services, Strategy and Financial Analysis

37. Testosterone Replacement Therapy Market Other Major And Innovative Companies

• Clarus Therapeutics Inc., Eli Lilly and Company, Endo International plc, Pfizer Inc., Teva Pharmaceutical Industries Limited, Acrux Limited, Aytu BioPharma Inc., Cipla Limited, Sun Pharmaceutical Industries Limited, Mylan N.V., Bausch Health Companies Inc., Sandoz International GmbH, Besins Healthcare, Coloplast A/S, Recordati S.p.A.

38. Global Testosterone Replacement Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Testosterone Replacement Therapy Market

40. Testosterone Replacement Therapy Market High Potential Countries, Segments and Strategies

• 40.1 Testosterone Replacement Therapy Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Testosterone Replacement Therapy Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Testosterone Replacement Therapy Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer